SaniGuard-SF

Product NDC: 58575-150
11-digit product format: 585750150
Labeler code: 58575
Product ID: 58575-150_e2ae02d1-6f7e-4192-e053-2a95a90aa3be
Type: HUMAN OTC DRUG
Nonproprietary name: ALCOHOL
Dosage form: LIQUID
Route: TOPICAL
Labeler: Inopak. Ltd
Application: part333E
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2011-05-01
Marketing end: 0000-00-00
Substance: ALCOHOL
Active strength: 70 mL/100mL
NDC exclude flag: No
Listing certified through: 2023-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 10 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	58575-150		I	Inactivated by FDA	2026-09-14
excluded package	package	58575-150	58575-150-01	I	Inactivated by FDA	2026-09-14
excluded package	package	58575-150	58575-150-02	D	Discontinued by firm	2026-09-14
excluded package	package	58575-150	58575-150-03	I	Inactivated by FDA	2026-09-14
excluded package	package	58575-150	58575-150-10	D	Discontinued by firm	2026-09-14
excluded package	package	58575-150	58575-150-12	D	Discontinued by firm	2026-09-14
excluded package	package	58575-150	58575-150-18	I	Inactivated by FDA	2026-09-14
excluded package	package	58575-150	58575-150-37	D	Discontinued by firm	2026-09-14
excluded package	package	58575-150	58575-150-42	I	Inactivated by FDA	2026-09-14
excluded package	package	58575-150	58575-150-80	I	Inactivated by FDA	2026-09-14

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 3 · 138 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-42	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-80	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-18	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-12	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-03	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-10	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-01	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-02	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	58575-150-37	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-42	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-80	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-18	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-12	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-03	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-10	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-01	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-02	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	58575-150-37	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-42	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-80	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-18	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-12	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-03	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-10	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-01	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-02	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	58575-150-37	D	Discontinued by firm	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-42	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-80	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-18	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-12	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-03	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-10	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-01	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-02	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	58575-150-37	D	Discontinued by firm	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-42	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-80	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-18	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-12	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-03	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-10	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-01	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-02	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	58575-150-37	D	Discontinued by firm	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-42	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-80	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-18	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-12	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-03	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-10	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-01	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-02	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	58575-150-37	D	Discontinued by firm	`cdf11ea48f46…`	`ba0047e9e063…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Related label table
NDC	Related label
58575-150-01	Inopak SaniGuard-SF
58575-150-02	Inopak SaniGuard-SF
58575-150-03	Inopak SaniGuard-SF
58575-150-10	Inopak SaniGuard-SF
58575-150-12	Inopak SaniGuard-SF
58575-150-18	Inopak SaniGuard-SF
58575-150-37	Inopak SaniGuard-SF
58575-150-42	Inopak SaniGuard-SF
58575-150-80	Inopak SaniGuard-SF

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	SPL version
58575-150-01	SaniGuard-SF	1000 mL in 1 POUCH	LIQUID	1000	6
58575-150-02	SaniGuard-SF	60 mL in 1 BOTTLE	LIQUID	60	6
58575-150-03	SaniGuard-SF	50 mL in 1 BOTTLE	LIQUID	50	6
58575-150-10	SaniGuard-SF	1000 mL in 1 BAG	LIQUID	1000	6
58575-150-12	SaniGuard-SF	1250 mL in 1 BAG	LIQUID	1250	6
58575-150-18	SaniGuard-SF	540 mL in 1 BOTTLE	LIQUID	540	6
58575-150-37	SaniGuard-SF	3840 mL in 1 BAG	LIQUID	3840	6
58575-150-42	SaniGuard-SF	3800 mL in 1 BOTTLE	LIQUID	3800	6
58575-150-80	SaniGuard-SF	800 mL in 1 BOTTLE	LIQUID	800	6

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ALCOHOL	ACTIVE INGREDIENT	3K9958V90M	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
ALCOHOL	ACTIVE MOIETY	3K9958V90M	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
BENZALKONIUM CHLORIDE	INACTIVE INGREDIENT	F5UM2KM3W7	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
CHLORHEXIDINE GLUCONATE	INACTIVE INGREDIENT	MOR84MUD8E	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
ISOPROPYL ALCOHOL	INACTIVE INGREDIENT	ND2M416302	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
PEG-10 DIMETHICONE (600 CST)	INACTIVE INGREDIENT	8PR7V1SVM0	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
POLYETHYLENE GLYCOL 600000	INACTIVE INGREDIENT	2126FD486L	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
POLYQUATERNIUM-10 (30000 MPA.S AT 2%)	INACTIVE INGREDIENT	C7RDC8Y4JS	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
58575-150	SANIGUARD-SF (ALCOHOL) LIQUID [INOPAK. LTD]	6	Legacy NDC, 9 package rows	20220702_f05b8a05-1eb8-4734-90e0-9948e685854c.zip

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
3K9958V90M	ALCOHOL	64-17-5	ALCOHOL

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
616805	ethanol 70 % Topical Foam	PSN	f05b8a05-1eb8-4734-90e0-9948e685854c	6
616805	ethanol 0.7 ML/ML Topical Foam	SCD	f05b8a05-1eb8-4734-90e0-9948e685854c	6
616805	ethanol 70 % Topical Foam	SY	f05b8a05-1eb8-4734-90e0-9948e685854c	6

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
58575-150-01	58575015001	1000 mL in 1 POUCH (58575-150-01)	1000 ml	2021-04-20	0000-00-00	No	No	Current
58575-150-02	58575015002	60 mL in 1 BOTTLE (58575-150-02)	60 ml	2011-05-01	0000-00-00	No	No	Current
58575-150-03	58575015003	50 mL in 1 BOTTLE (58575-150-03)	50 ml	2021-04-20	0000-00-00	No	No	Current
58575-150-10	58575015010	1000 mL in 1 BAG (58575-150-10)	1000 ml	2011-05-01	0000-00-00	No	No	Current
58575-150-12	58575015012	1250 mL in 1 BAG (58575-150-12)	1250 ml	2011-05-01	0000-00-00	No	No	Current
58575-150-18	58575015018	540 mL in 1 BOTTLE (58575-150-18)	540 ml	2011-05-01	0000-00-00	No	No	Current
58575-150-37	58575015037	3840 mL in 1 BAG (58575-150-37)	3840 ml	2011-05-01	0000-00-00	No	No	Current
58575-150-42	58575015042	3800 mL in 1 BOTTLE (58575-150-42)	3800 ml	2021-04-20	0000-00-00	No	No	Current
58575-150-80	58575015080	800 mL in 1 BOTTLE (58575-150-80)	800 ml	2011-05-01	0000-00-00	No	No	Current